Cited by 765Cancer, Hypoxia, and MetabolismAngiogenesis and VEGF in CancerErythropoietin and Anemia Treatment

Hypoxia and cancer

Open access
Brahimi-Horn, M. Christiane, Chiche, Johanna, Pouysségur, Jacques·2007·Journal of Molecular Medicine

Abstract

A major feature of solid tumours is hypoxia, decreased availability of oxygen, which increases patient treatment resistance and favours tumour progression. How hypoxic conditions are generated in tumour tissues and how cells respond to hypoxia are essential questions in understanding tumour progression and metastasis. Massive tumour-cell proliferation distances cells from the vasculature, leading to a deficiency in the local environment of blood carrying oxygen and nutrients. Such hypoxic conditions induce a molecular response, in both normal and neoplastic cells, that drives the activation of a key transcription factor; the hypoxia-inducible factor. This transcription factor regulates a large panel of genes that are exploited by tumour cells for survival, resistance to treatment and escape from a nutrient-deprived environment. Although now recognized as a major contributor to cancer progression and to treatment failure, the precise role of hypoxia signalling in cancer and in prognosis still needs to be further defined. It is hoped that a better understanding of the mechanisms implicated will lead to alternative and more efficient therapeutic approaches.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00109-007-0281-3

Cites

62 of 62 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • HIF-1 is a master regulator of hypoxia and oxygen homeostasis.

    “A master regulator of hypoxia and oxygen homeostasis is HIF-1 (26,27).”

    From Adipose tissue remodeling and obesity (2011) · cites this paper as [26]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

Research works printed but not linked: 1

  1. Chiche J, Laferrière J, Trottier E, Roux D, Mazure N, Brahimi- Horn MC, Pouysségur J (2007) The hypoxia-induced tumor marker carbonic anhydrase IX plays a critical role in tumor microenvironmental pH homeostasis. Keystone Symposium Con- ference. Molecular Targets for Cancer. Abstract # 134, Whistler, British Columbia, 18-23 March

Cited by

Sorted by citations

Authors
Brahimi-Horn, M. C., Chiche, J., & Pouysségur, J.
Affiliations
Centre National de la Recherche Scientifique (FR)
Corresponding author
Brahimi-Horn, M. Christiane
Venue
Journal of Molecular Medicine
Published
2007-11-20
Volume
85
Issue
12
Pages
1301-1307
ISSN
  • 0946-2716 (ISSN-L)
  • 1432-1440
OpenAlex
W2151029652
Cited by
765
References
62
Citations by year
2026: 15 · 2025: 31 · 2024: 60 · 2023: 49 · 2022: 58 · 2021: 65 · 2020: 36 · 2019: 25 · 2018: 31 · 2017: 39 · 2016: 42 · 2015: 44 · 2014: 30 · 2013: 53 · 2012: 38
FWCI
2.91
Type
journal article
Language
en
Open access
Locations
  • Journal of Molecular Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
Funders
  • Institut National de la Santé et de la Recherche Médicale
  • Centre National de la Recherche Scientifique
  • Institut National Du Cancer
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
  • Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
Keywords
tumor hypoxia, hypoxia-inducible factor, tumor progression, treatment resistance, metastasis, tumor vasculature, hypoxia signaling, tumor cell survival, tumor microenvironment, prognosis, therapeutic target
MeSH terms
Animals, Hypoxia, Antineoplastic Agents, Humans, Hydrogen-Ion Concentration, Neoplasm Metastasis, Neoplasms, Neovascularization, Pathologic, Oxygen, Phenotype, Prognosis, Signal Transduction, Cell Hypoxia, Cell Death, Angiogenesis Inhibitors, Cell Proliferation, Hypoxia-Inducible Factor 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review